AAAAAA

   
Results: 1-15 |
Results: 15
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy
Authors: Shulman, N Zolopa, AR Passaro, D Shafer, RW Huang, W Katzenstein, D Israelski, DM Hellmann, N Petropoulos, C Whitcomb, J
Citation: N. Shulman et al., Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy, AIDS, 15(9), 2001, pp. 1125-1132
Plasma carnitine in HIV-associated neuropathy
Authors: Simpson, DM Katzenstein, D Haidich, B Millington, D Yiannoutsos, C Schifitto, G McArthur, J
Citation: Dm. Simpson et al., Plasma carnitine in HIV-associated neuropathy, AIDS, 15(16), 2001, pp. 2207-2208
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy
Authors: Schifitto, G Yiannoutsos, C Simpson, DM Adornato, BT Singer, EJ Hollander, H Marra, CM Rubin, M Cohen, BA Tucker, T Koralnik, IJ Katzenstein, D Haidich, B Smith, ME Shriver, S Millar, L Clifford, DB McArthur, JC
Citation: G. Schifitto et al., Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy, NEUROLOGY, 57(7), 2001, pp. 1313-1316
Prescribing practices and attitudes toward giving children antibiotics
Authors: Paluck, E Katzenstein, D Frankish, CJ Herbert, CP Milner, R Speert, D Chambers, K
Citation: E. Paluck et al., Prescribing practices and attitudes toward giving children antibiotics, CAN FAM PHY, 47, 2001, pp. 521-527
Prenatal transmission of subtype CHIV-1 in Zimbabwe: HIV-1 RNA and DNA in maternal and cord blood
Authors: Guevara, H Johnston, E Zijenah, L Tobaiwa, O Mason, P Contag, C Mahomed, K Hendry, M Katzenstein, D
Citation: H. Guevara et al., Prenatal transmission of subtype CHIV-1 in Zimbabwe: HIV-1 RNA and DNA in maternal and cord blood, J ACQ IMM D, 25(5), 2000, pp. 390-397
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan
Authors: DeGruttola, V Dix, L D'Aquila, R Holder, D Phillips, A Ait-Khaled, M Baxter, J Clevenbergh, P Hammer, S Harrigan, R Katzenstein, D Lanier, R Miller, M Para, M Yerly, S Zolopa, A Murray, J Patick, A Miller, V Castillo, S Pedneault, L Mellors, J
Citation: V. Degruttola et al., The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan, ANTIVIR TH, 5(1), 2000, pp. 41-48
Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis
Authors: Babiker, A Bartlett, J Breckenridge, A Collins, G Coombs, R Cooper, D Creagh, T Cross, A Daniels, M Darbyshire, J Dawson, D DeGruttola, V DeMasi, R Dolin, R Eron, J Fischl, M Grossberg, S Hamilton, J Hammer, S Hartigan, P Henry, K Hill, A Hughes, M Kahn, J Katlama, C Katzenstein, D Kim, S Mildvan, D Montaner, J Moore, M Neaton, J O'Brien, W Ribaudo, H Richman, D Saag, M Salgo, M Saravolatz, L Schooley, R Seligmann, M Staszewski, S Struthers, L Tierney, C Tsiatis, A Welles, S
Citation: A. Babiker et al., Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis, AIDS RES H, 16(12), 2000, pp. 1123-1133
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884
Authors: Fletcher, CV Acosta, EP Cheng, HL Haubrich, R Fischl, M Raasch, R Mills, C Hu, XJ Katzenstein, D Remmel, RP Gulick, RM
Citation: Cv. Fletcher et al., Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884, AIDS, 14(16), 2000, pp. 2495-2501
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection
Authors: McArthur, JC Yiannoutsos, C Simpson, DM Adornato, BT Singer, EJ Hollander, H Marra, C Rubin, M Cohen, BA Tucker, T Navia, BA Schifitto, G Katzenstein, D Rask, C Zaborski, L Smith, ME Shriver, S Millar, L Clifford, DB
Citation: Jc. Mcarthur et al., A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection, NEUROLOGY, 54(5), 2000, pp. 1080-1088
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359
Authors: Gulick, RM Hu, XJ Fiscus, SA Fletcher, CV Haubrich, R Cheng, HL Acosta, E Lagakos, SW Swanstrom, R Freimuth, W Snyder, S Mills, C Fischl, M Pettinelli, C Katzenstein, D
Citation: Rm. Gulick et al., Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359, J INFEC DIS, 182(5), 2000, pp. 1375-1384
Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women
Authors: Lampinen, TM Kulasingam, S Min, JN Borok, M Gwanzura, L Lamb, J Mahomed, K Woelk, GB Strand, KB Bosch, ML Edelman, DC Constantine, NT Katzenstein, D Williams, MA
Citation: Tm. Lampinen et al., Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women, J INFEC DIS, 181(5), 2000, pp. 1785-1790
Comparison of gynecologic history and laboratory results in HIV-positive women with CD4(+) lymphocyte counts between 200 and 500 cells/mu l and below100 cells/mu l
Authors: Watts, DH Spino, C Zaborski, L Katzenstein, D Hammer, S Benson, C
Citation: Dh. Watts et al., Comparison of gynecologic history and laboratory results in HIV-positive women with CD4(+) lymphocyte counts between 200 and 500 cells/mu l and below100 cells/mu l, J ACQ IMM D, 20(5), 1999, pp. 455-462
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence
Authors: Abrams, D Allan, D Antunes, F Breckenridge, A Bruun, J Cameron, W Carbon, C Chalmers, I Chang, H Chodakewitz, J Clendenin, N Clumeck, N Collier, A Collins, G Cooper, E Cooper, D Danner, S D'Aquila, R DeGruttola, V DeMasi, R Dee, L Deyton, L Dixon, D Farthing, C Feinberg, J Fischl, M Flepp, M Gartland, M Gatell, J Gazzard, B Goebel, F Gotzsche, P Gringeri, A Hall, D Hamilton, J Hammer, S Hartigan, P Heath-Chiozzi, M Henry, K Hill, A Hirschel, B Ioannidis, J Kahn, J Katlama, C Katzenstein, D Killen, J King, E de Loes, SK Kravcik, S Lange, J Leavitt, R Leonard, J Maeland, A Mannucci, P Mathiesen, L McDade, H Meibohn, A Melander, H Merigan, T Mulder, J Myers, M Neaton, J Nessling, M Perrin, L Pettinelli, C Phair, J Phillips, A Pinching, A Poppa, A Power, L Reiss, P Richman, D Rooney, J Rousseau, F Rutherford, G Salgo, M Sandstrom, E Saravolatz, L Savidge, G Schnittman, S Schooley, R Seligmann, M Simberkoff, M Skowron, G Slade, P Smith, D Smith, RP Soriano, V Stanley, K Stingl, G Stoffels, P Struthers, L Tierney, C Thompson, M Van der Broeck, R Van Leeuven, R Van Weverling, G Veenstra, J Vella, S Volberding, P Weber, J Winslow, D Yeni, P Yeo, J Dormont, J Sande, M Weller, I Babiker, A Collins, R Darbyshire, J Duncan, W Foulkes, M Hughes, M Peto, R Peto, T Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers
Authors: McFarland, W Gwanzura, L Bassett, MT Machekano, R Latif, AS Ley, C Parsonnet, J Burke, RL Katzenstein, D
Citation: W. Mcfarland et al., Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers, J INFEC DIS, 180(5), 1999, pp. 1459-1465
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed
Authors: Zolopa, AR Shafer, RW Warford, A Montoya, JG Hsu, P Katzenstein, D Merigan, TC Efron, B
Citation: Ar. Zolopa et al., HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed, ANN INT MED, 131(11), 1999, pp. 813
Risultati: 1-15 |